Lifetime Exposure to Estrogen and Neuroimaging outcomes in older women in the IGNITE trial

Abstract

Lower lifetime estrogen exposure is associated with age- and Alzheimer’s-related reductions in brain volume, while estrogen-based therapies are associated with larger volume.